Common Contracts

6 similar Underwriting Agreement contracts by Celsion CORP, Chanticleer Holdings, Inc., Healthy Choice Wellness Corp., others

UNDERWRITING AGREEMENT
Underwriting Agreement • August 30th, 2024 • Healthy Choice Wellness Corp. • Retail-grocery stores • New York

The undersigned, Healthy Choice Wellness Corp., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates (which, for the avoidance of doubt, does not include Healthier Choices Management Corp (“HCMC”)), including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Healthy Choice Wellness Corp., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth

Vislink Technologies, Inc. 3,201,200 Shares Common Stock ($0.00001 par value per share) 11,893,100 Pre-Funded Warrants to Purchase up to 11,893,100 Shares of Common Stock and 15,094,300 Warrants to Purchase up to 11,320,725 Shares of Common Stock...
Underwriting Agreement • November 27th, 2019 • Vislink Technologies, Inc. • Communications equipment, nec • New York

Vislink Technologies, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as Representative, (i) an aggregate of 3,201,200 shares of common stock, par value $0.00001 per share (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Firm Shares”), (ii) 11,893,100 pre-funded warrants to purchase up to an aggregate of 11,893,100 shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.001 per share and (iii) 15,094,300 warrants of the Company to purchase up to an aggregate of 11,320,725 shares of Common Stock (the “Firm Common Warrants”) at an exercise price equal to $0.2915 per share. The Firm Shares, the Pre-Funded Warrants, and the Firm Common Warrants to be sold by the Company are collectively referred to as the

COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreement • December 21st, 2017 • LiveXLive Media, Inc. • Retail-eating places • New York
Shares of Common Stock (or Pre-Funded Warrants to Purchase Shares of Common Stock in Lieu Thereof) and Warrants to Purchase __________ Shares of Common Stock CELSION CORPORATION UNDERWRITING AGREEMENT
Underwriting Agreement • June 2nd, 2017 • Celsion CORP • Pharmaceutical preparations • New York

Celsion Corporation, a Delaware corporation (the “Company”) proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), (i) an aggregate of ________ shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”) or pre-funded warrants (the “Pre-Funded Warrants”) to purchase Common Stock in lieu thereof at an exercise price of $0.01 per share (the “Pre-Funded Warrant Shares”) and (ii) warrants (the “Firm Warrants” and collectively with the Firm Shares, the “Firm Securities”) to purchase up to an aggregate of [ ] shares of Common Stock (the “Warrant Shares”). The respective amounts of the Firm Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an o

Shares VIKING THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • April 10th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • New York

Viking Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained in this agreement (this “Agreement”), to sell to you and the other underwriters named on Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of shares (the “Firm Shares”) of the Company’s common stock, $0.00001 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively referred to herein as the “Shares.”

Chanticleer Holdings, Inc. 2,444,450 Units UNDERWRITING AGREEMENT
Underwriting Agreement • June 27th, 2012 • Chanticleer Holdings, Inc. • Services-management consulting services • Florida

Chanticleer Holdings, Inc, a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (each of Merriman Capital, Inc. and Dawson James Securities, Inc., collectively referred to herein as the “Representative” or “you”) an aggregate of 2,444,450 units (the “Firm Units”) at a price of $4.23 per Unit, with each unit consisting of one share of the Company’s common stock, $0.0001 par value (the “Common Stock”), and one warrant (“Warrant”) to purchase one share of Common Stock. The respective amounts of Firm Units to be so purchased by each of the several Underwriters are set forth opposite their respective names in Schedule I hereto. The Company also proposes to sell, at the Underwriters’ option (“Overallotment Option”), an aggregate of up to 366,667 additional units of the Company (the “Option Units”) as set forth below. The terms of the Warrants are provided for in the form